Vertex Pharmaceuticals Incorporated (VRTX)
Market Closed
18 Jun, 20:00
$
451. 63
-7.36
-1.6035%
$
116.49B Market Cap
30.83 P/E Ratio
- Div Yield
2.99M Volume
14.94 Eps
$ 458.99
Previous Close 
Want to track VRTX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Vertex Pharmaceuticals Incorporated (VRTX) Statistics
Valuation metrics
Market Cap 116.49B
Enterprise value 109.42B
Trailing P/E (ttm) 26.06
Forward P/E 19.95
PEG ratio 0.04
Price/Sales (ttm) 9.21
Price/Book (mrq) 5.84
Enterprise Value/Revenue 8.93
Enterprise Value/EBITDA 21.1
Overview
Shares outstanding 254.16M
Float 253.02M
Shares short 4.17M
% Held by insiders 0%
% Held by institutions 0.98%
Average volume (10 days) 918.77K
Average volume (90 days) 1.25M
Price summary
52-Week low 362.5
52-Week high 507.92
Beta 0.3
50-Day moving average 434.28
200-Day moving average 453.22
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 2:1
Last split Date 24 Aug 2000
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Mar 2026
Profitability
Profit margin 0.35%
Operating margin 0.39%
Operational effectiveness
Return on assets 0.16%
Return on equity 0.24%
Income Statement
Revenue (ttm) 12.22B
Revenue per share (ttm) 48.23
Quarterly revenue growth (yoy) 0.08%
Gross profit (ttm) 6.65B
EBITDA 5.26B
Net income to common (ttm) 4.34B
Diluted EPS (ttm) 17.07
Quarterly earnings growth (yoy) 0.6%
Balance Sheet
Total cash (mrq) 7.25B
Total cash per share (mrq) 28.52
Total debt (mrq) 1.99B
Total Debt/Equity (mrq) 0.1
Current ratio (mrq) 3.02%
Book value per share (mrq) 76.2
Cash Flow
Cash flow statement 4.24B
Levered free cash flow (LFCF) 2.78B
